Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSRP3 and E2F8 antisense RNA 1 (CSRP3-AS1) is a gene that encodes a long non-coding RNA molecule. It is located in proximity to the protein-coding CSRP3 gene, which is involved in cardiac muscle differentiation and associated with cardiomyopathies. CSRP3-AS1 is classified as an antisense RNA, implying potential involvement in regulating the expression of nearby genes such as CSRP3 and E2F8, although its specific biological roles, molecular interactions, and disease associations are minimally characterized. There are no documented drug interactions, biomarker qualities, or direct links to therapeutic targeting in current literature[6][7]. Variants in the region have been associated with blood cell parameters and lipid traits, but these associations are not definitively attributed to CSRP3-AS1 alone[1]. If further structured information becomes available about its function or therapeutic relevance, this record can be updated.
None documented
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CSRP3 and E2F8 antisense RNA 1 (CSRP3-AS1).